Category Archives: Right to Health

NIH urged to ‘break taboo’ against using its power to bypass drug patents

Organizations echo Congress in demanding ‘march-in’ action from feds By Emily Wasserman, FiercePharma|January 14, 2016   The National Institutes of Health (NIH) has said that it would take “extraordinary” circumstances to use its little-known power to bypass certain drug patents. … Continue reading

Posted in Bayh Dole Act, Compulsory Licensing, Right to Health, Uncategorized | Leave a comment

Cipla’s audacious move

Source: Down to Earth Why generics maker Cipla has asked government to revoke Novartis patent on respiratory ailment drug   India’s fourth largest pharmaceuticals company Cipla has thrown a bombshell. It has made a generic version of a patented Novartis … Continue reading

Posted in IP Rights, Patents, Pricing, Right to Health | Leave a comment

Let India Make Cheap Drugs

Source: NY Times NEW HAVEN, Conn. — Last month, the United States and India announced an important breakthrough concerning India’s “right-to-food” program. The Indian government subsidizes food for its poorest citizens through a system of price supports and public stockpiling. The … Continue reading

Posted in Generics, HIV/Aids, IP Rights, Patents, Pricing, Right to Health, WTO | Leave a comment

Class Action Lawsuit Challenges the Exorbitant Pricing of Gilead’s Hepatitis-C Drug Sovaldi

Source: PR Newswire HAVERFORD, Pa., Dec. 9, 2014 /PRNewswire/ — Chimicles & Tikellis LLP of Haverford, PA today announced that it has filed a lawsuit on behalf of the Southeastern Pennsylvania Transportation Authority (“SEPTA”) in federal court in Philadelphia, PA … Continue reading

Posted in Hepatitis C, IP Rights, Patents, Right to Health, Sofosbuvir | Leave a comment

India asks RCEP members to focus on value addition in services

Source: Zee News New Delhi: India has asked RCEP members, including ASEAN nations, China and Korea, to focus on value addition in services, besides working towards to improving investment climate to spur trade and boost growth in the region. “The … Continue reading

Posted in Asean, IP Rights, Patents, Regional Comprehensive Economic Partnership, Right to Health, Trade Agreements | Tagged , | Leave a comment

RCEP protest in India at Udyog Bhawan (Ministry of Commerce)

3 December 2014-People living with HIV led by DNP+ protested at the gates of Ministry of Commerce today to warn Nirmala Sitharaman, Indian Commerce Minister about harmful intellectual property (IP) provisions – put forth by Japan in RCEP- negotiations for … Continue reading

Posted in IP Rights, Regional Comprehensive Economic Partnership, Right to Health | Leave a comment

People Living With HIV Rally in Streets of Delhi as India Hosts RCEP Trade Negotiations

Source: MSF Access Campaign Third meeting of RCEP Working Group on Intellectual Property begins New Delhi, 3 December 2014: As the 6th round of negotiations on the Regional Comprehensive Economic Partnership (RCEP)trade agreement take place in India, people living with HIV … Continue reading

Posted in Asean, Data Exclusivity, IP Rights, Patent Term Extension, Patents, Regional Comprehensive Economic Partnership, Right to Health, Sec 3 (d), TPP, Trade Agreements | Leave a comment